Introduction
Substance dependence among prisoners is not merely a disciplinary issue; it is a public-health, human-rights, and criminal-justice concern. Prisoners may enter custody with existing addictions, while stress, withdrawal, and the prison environment can worsen dependence and increase relapse risks. International evidence suggests that about one in three prisoners uses drugs during incarceration.
In India, the challenge is intensified by overcrowding, a large undertrial population, and limited access to addiction treatment. As of 31 December 2023, India had 389,910 undertrial prisoners, compared with 135,536 convicts. Recent reports from Punjab further highlight the seriousness of the problem, with nearly 50% of prisoners reported as drug-dependent.
Effective prison policy must therefore move beyond drug control and punishment. It should focus on early screening, safe withdrawal management, medical and psychological treatment, rehabilitation, relapse prevention, and continued care after release.
Treat Addiction as a Health Disorder, Not Merely Misconduct
The first principle should be a change in institutional thinking. Addiction is a chronic and treatable health disorder. A prisoner who experiences withdrawal, craving, or relapse should not automatically be treated as a disciplinary offender.
The Nelson Mandela Rules recognize healthcare as a state responsibility and require prisoners to receive healthcare comparable to that available in the community. UNODC guidance similarly stresses continuity of care for drug dependence when individuals enter and leave prison.
Accordingly, prison administrations should distinguish between:
- possession or trafficking of prohibited substances, which may require disciplinary or criminal action; and
- drug dependence itself, which requires medical assessment and treatment.
This distinction can prevent punishment from replacing therapy.
Conduct Universal Screening at Prison Admission
Every new prisoner should undergo confidential screening for substance use during the initial medical examination. The screening should identify alcohol and opioid dependence, cannabis and stimulant use, misuse of prescription drugs, previous overdose or withdrawal problems, past treatment, mental health conditions, and risks related to HIV, hepatitis, and self-harm. Screening should be used mainly for early identification, medical risk assessment, and treatment planning, not for punishment or stigmatization. Evidence from the AIIMS National Drug Dependence Treatment Centre (NDDTC) also highlights the importance of studying substance-use patterns among prisoners to develop effective, evidence-based treatment programs.
Provide Safe Withdrawal Management
Sudden withdrawal can be dangerous, especially for prisoners dependent on alcohol, benzodiazepines, or opioids. Therefore, withdrawal should be managed under proper medical supervision rather than through forced abstinence. Jails should conduct withdrawal-risk assessments at admission, provide medically supervised detoxification, ensure emergency care for seizures and overdose, maintain access to trained medical staff, and arrange referrals to government hospitals when necessary. Detoxification is only the beginning of treatment; it must be followed by proper rehabilitation and continuing care.
Expand Opioid Agonist Treatment
For prisoners with opioid dependence, opioid agonist treatment (OAT) should be a central component of prison healthcare.
India’s National AIDS Control Organisation recognizes opioid-substitution treatment as part of its harm-reduction strategy. NACO states that OST helps reduce cravings and withdrawal symptoms and can reduce injection-related risks, including HIV and other blood-borne infections. Importantly, the program includes prisons and other closed settings. (NACO)
Treatment should include appropriate medications, clinical monitoring, and psychosocial counselling. It should not be discontinued merely because a person enters custody.
Evidence-based standards further indicate that continuing or initiating opioid agonist treatment in prison can reduce the risk of opioid overdose following release.
Ensure Overdose Prevention After Release
The period immediately after release can be especially risky for people with opioid dependence because reduced drug use may lower tolerance and increase the risk of overdose if drug use resumes. Prison-release programs should therefore provide overdose education, naloxone, appropriate training, continued medication, emergency guidance, and referral to community addiction services. Treatment should continue without unnecessary interruption after release. The day of release should be treated as an important healthcare transition, not merely an administrative discharge.
Integrate Mental Health and Addiction Treatment
Substance dependence often occurs along with depression, anxiety, trauma, and other mental health problems, so both issues should be treated together. According to NCRB’s Prison Statistics India 2023, 9,095 prisoners were reported as suffering from mental illness, including 5,293 undertrials. Prisons should therefore provide access to psychiatrists, psychologists, counsellors, psychiatric nurses, social workers, and addiction specialists, with proper assessment of trauma, self-harm, suicidal behavior, and other mental health risks. Integrated mental health and addiction care is essential for effective recovery and rehabilitation.
Provide Psychological and Behavioral Support
Medication alone cannot fully address the psychological, social, and behavioral aspects of addiction. Prison treatment programmes should therefore include counselling, cognitive behavioural therapy, motivational interviewing, relapse-prevention training, group and peer support, stress and anger management, and family counselling. Therapeutic communities and specialized rehabilitation units can also be established for prisoners who need intensive support. Such integrated care can improve recovery and reduce the risk of relapse after release.
Create Dedicated De-Addiction Units
Large jails should consider establishing dedicated addiction-treatment units rather than attempting to deliver all services within ordinary prison wards.
Such units could provide:
Assessment → Detoxification → Medication → Counselling → Rehabilitation → Relapse Prevention → Pre-release Planning
Separate treatment environments can reduce exposure to drugs and negative peer influences while allowing healthcare professionals to provide more intensive services. UNODC-WHO guidance specifically recognizes dedicated residential environments as an appropriate model for high-risk populations. However, segregation should never become punitive isolation. The purpose must remain treatment, dignity, and recovery.
Balance Drug Control with Health Measures
Preventing drugs from entering prisons is important, but security measures alone cannot eliminate addiction. A comprehensive approach should combine effective security, monitoring of prison supply chains, proper screening of visitors and staff, detection of new psychoactive substances, confidential reporting systems, and timely treatment for prisoners with substance dependence. India should also strengthen research and monitoring of emerging drugs. The overall goal should be “less supply, less demand, and less harm.”
Provide Specialized Support for Women and Young Prisoners
Addiction treatment should be tailored to the individual needs of different groups rather than following a one-size-fits-all approach. Women prisoners may need trauma-informed care, reproductive-health support, childcare assistance, and protection from gender-based violence, while young prisoners may benefit from education, vocational training, family support, life-skills programs, peer guidance, and relapse-prevention counselling. The WHO-UNODC standards also emphasize special treatment and care for women and young offenders.
Give Undertrials Equal Access to Treatment
A major weakness in prison healthcare is the possibility that treatment becomes linked to conviction status. This is particularly problematic in India because the undertrial population is enormous. Government figures for 31 December 2023 recorded 389,910 undertrials, far exceeding the number of convicts. An undertrial prisoner with opioid dependence should not lose access to clinically necessary treatment simply because the criminal case is pending. Treatment must follow the medical need of the individual, not the procedural stage of the criminal case.
Provide an Individual Recovery Plan
Every prisoner diagnosed with a substance-use disorder should receive an Individual Recovery Plan (IRP) based on their medical condition, treatment needs, mental health, family and social circumstances, education and employment goals, relapse risks, and plans for treatment after release. The plan should also include appropriate medication, psychological support, and overdose prevention. It should be regularly reviewed and updated to ensure that treatment remains suitable and effective throughout the prisoner’s rehabilitation.
Strengthen Peer and Family Support
Recovery is more successful when prisoners have positive social and family support. Trained peer educators can encourage treatment, identify early signs of relapse, provide guidance, reduce stigma, and help prisoners access available services. Families should also be involved, with the prisoner’s consent, through counselling and awareness programs to improve their understanding of addiction and prepare them for the prisoner’s reintegration into society.
Link Addiction Treatment with Education and Employment
Addiction is often linked with unemployment, poverty, homelessness, family problems, and social exclusion. Therefore, prison rehabilitation should combine addiction treatment with education, vocational training, employment support, family assistance, financial literacy, housing support, and community-based rehabilitation. Providing these opportunities can help prisoners rebuild their lives after release and reduce the risk of relapse and reoffending. Recovery becomes more sustainable when treatment is supported by education, employment, and social stability.
Build a “Continuity of Care” System After Release
Perhaps the most important reform is ensuring that treatment does not end at the prison gate.
At least several weeks before release, every prisoner receiving addiction treatment should be linked to a community service. The discharge plan should include:
Prison treatment → Community treatment center → Medication continuity → Counselling → Housing/employment support → Follow-up
UNODC emphasizes that interruption of treatment upon release can undermine health and social reintegration, while the post-release period represents a particularly vulnerable period for people with opioid-use disorders.
A designated prison-to-community recovery coordinator could ensure that no released prisoner leaves without a treatment referral.
Develop a National Prison Addiction Dashboard
India needs a standardized system for collecting and monitoring prison addiction data. Prison departments should maintain updated, anonymized records on screening, substance-use disorders, withdrawal and overdose cases, treatment enrollment and completion, relapse, referrals after release, and substance-related deaths. Such data should guide prison-health planning and policy-making while protecting prisoners’ medical confidentiality. Better and reliable data are essential for understanding the extent of substance addiction in Indian prisons and developing effective treatment and rehabilitation programs.
Measure Success by Recovery, Not Merely Drug Seizures
Traditional prison metrics often focus on the quantity of drugs seized, disciplinary cases registered, or contraband detected. These remain relevant for security, but they cannot measure recovery.
A modern prison addiction program should measure:
- Treatment initiation
- Treatment retention
- Reduced drug use
- Improved mental health
- Reduced overdose
- Successful community linkage
- Reduced recidivism
The ultimate question should not be simply “How many drugs were seized?” but “How many lives were restored?”
Strengthen Legal and Institutional Coordination
Effective management of substance addiction in prisons requires close coordination among prison authorities, health departments, legal-services authorities, NACO, NCB, hospitals, de-addiction centers, mental-health professionals, NGOs, and community-health workers. Families and released prisoners should also be involved in rehabilitation and follow-up care. Health authorities should primarily handle medical treatment and rehabilitation, while prison authorities should ensure security and proper institutional support. Such coordination will help ensure that addiction is treated as a health issue rather than merely a disciplinary matter.
Conclusion: From Custody to Recovery
Substance addiction in Indian jails requires more than punishment or drug-control measures. A health-centered and rehabilitation-based approach should include early screening, safe withdrawal management, medical and psychological treatment, relapse prevention, and continued care after release. The reported high level of drug dependence among prisoners in Punjab highlights the need to treat addiction as a serious prison-health issue. India should strengthen existing programs through trained staff, dedicated de-addiction facilities, reliable data, and effective community-based support. The true goal of imprisonment should not merely be to restrict drug use but to help prisoners break the cycle of addiction and rebuild their lives.
Legal Case Laws & Judicial Orders
| Case Law / Judicial Order | Principle |
|---|---|
| Francis Coralie Mullin v. Administrator, Union Territory of Delhi (1981) 1 SCC 608 | Supreme Court ruling that Article 21 includes the right to dignity and basic health care. |
| Parmanand Katara v. Union of India (1989) 4 SCC 286 | Supreme Court ruling on the obligation of medical professionals to preserve life without delay. |
| Rama Murthy v. State of Karnataka (1997) 2 SCC 642 | Supreme Court directions on prison reforms, overcrowding, and health conditions. |
| In re: Status Report on Drug Dependence in Punjab Prisons (Punjab & Haryana High Court, September 2026) | State status report on inmate addiction metrics and OOAT clinic coverage. |
Government & Institutional Reports
- National Crime Records Bureau (NCRB). Prison Statistics India 2023. Ministry of Home Affairs, Government of India.
- National AIDS Control Organisation (NACO). National Guidelines for Opioid Substitution Therapy (OST), 2021. Ministry of Health and Family Welfare.
- National Drug Dependence Treatment Centre (NDDTC). Magnitude of Substance Use in India, 2019. AIIMS, New Delhi.
International Guidelines & Standards
- United Nations General Assembly. United Nations Standard Minimum Rules for the Treatment of Prisoners (Nelson Mandela Rules), Resolution A/RES/70/175, 2015.
- UNODC & WHO. International Standards for the Treatment of Drug Use Disorders, 2018.
- World Health Organization. Guidelines for the Psychosocially Assisted Pharmacotherapy of Opioid Dependence, 2014.
